Table 3 Clinical complications and outcomes after pediatric liver transplantation
Outcomes | Serum HMGB1, ng/mL | P | ||
|---|---|---|---|---|
1st tertile (4.3–8.1 pg/mL) (n = 70) | 2nd tertile(8.2–10.6 pg/mL) (n = 69) | 3rd tertile (10.6–18.8 pg/mL) (n = 71) | ||
PARDS: n (%) |  |  |  | < 0.001 |
 No | 66 (94.3) | 51 (73.9) | 38 (53.5) |  |
 Yes | 4 (5.7) | 18 (26.1) | 33 (46.5) |  |
Mortality at 30 days after surgery: n (%) | Â | Â | Â | 0.276 |
 No | 70 (100) | 68 (98.6) | 68 (95.8) |  |
 Yes | 0 (0) | 1 (1.4) | 3 (4.2) |  |
Biliary/intestinal fistula: n (%) | Â | Â | Â | 0.666 |
 No | 66 (94.3) | 65 (94.2) | 69 (97.2) |  |
 Yes | 4 (5.7) | 4 (5.8) | 2 (2.8) |  |
Ileus: n (%) | Â | Â | Â | 0.762 |
 No | 66 (94.3) | 63 (91.3) | 65 (91.5) |  |
 Yes | 4 (5.7) | 6 (8.7) | 6 (8.5) |  |
Rejection reaction: n (%) | Â | Â | Â | 0.249 |
 No | 59 (84.3) | 52 (75.4) | 52 (73.2) |  |
 Yes | 11 (15.7) | 17 (24.6) | 19 (26.8) |  |
Lymphatic leakage: n (%) | Â | Â | Â | 0.140 |
 No | 41 (58.6) | 50 (72.5) | 51 (71.8) |  |
 Yes | 29 (41.4) | 19 (27.5) | 20 (28.2) |  |
Postoperative hospital stay time: Median (IQR), d | 19.0 (14.0 to 24.0) | 18.0 (14.0 to 25.0) | 21.0 (15.5 to 26.0) | 0.127 |
Postoperative ICU stay time: Median (IQR), d | 3.0 (2.0 to 3.0) | 2.0 (2.0 to 3.0) | 3.0 (2.0 to 4.0) | < 0.001 |
Postoperative respiratory support time: Median (IQR), min | 179.0 (143.0 to 305.0) | 195.0 (154.0 to 365.0) | 270.0 (175.5 to 637.5) | < 0.001 |